Ac2-26-Nanoparticles Induce Resolution of Intestinal Inflammation and Anastomotic Healing via Inhibition of NF-κB Signaling in a Model of Perioperative Colitis.
Philipp-Alexander NeumannJong Hyun LeeJoseph Raphael Elias MiltschitzkyVincent ViereggeRobert Leon WalterVanessa TwardyAtsuko KasajimaHelmut FriessNazila KamalyPhilipp-Alexander NeumannPublished in: Inflammatory bowel diseases (2022)
Proresolving therapy with Ac2-26-NPs promises to be a potent perioperative therapy because it improves colitis activity and even intestinal anastomotic healing by the suppression of proinflammatory signaling.